According to @AggrNews, Sonnet Biotherapeutics (SNTI) received stockholder approval for a business merger with Hyperliquid Strategies Inc, as reported by Reuters, source: Aggr News (X), Reuters. No deal terms, closing timeline, or digital-asset details were cited in the Reuters update relayed by Aggr News, and no direct crypto-market impact was stated, source: Aggr News (X), Reuters.